BSE filing, NSE: EUROPRATIK. Summary written from the filing by ALFA Finder's alert engine.
Euro Pratik Sales Ltd: key numbers
- Share price
- ₹169.10
- Market cap
- ₹1,728 Cr
- Revenue (annual)
- ₹335.0 Cr
- Net profit (annual)
- ₹77.09 Cr
- P/E (TTM)
- 20.1×Sector 34.0×
- Promoter holding
- 73.91%+0.00% QoQ
- FII holding
- 0.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Euro Pratik Sales Ltd
All →Euro Pratik Sales Board Meeting Date
Euro Pratik Sales Ltd intimated NSE of a board meeting on November 5, 2026, to consider audited standalone and consolidated half-yearly results for the period ended September 2026. Trading window stays closed until 48 hours after results declaration.
Euro Pratik Sales Merger & Restructuring Worth ₹42.7 Cr
Euro Pratik put its proposed ₹42.70 Crore Fabwood Solutions LLP stake acquisition on hold. Next steps are under evaluation with legal advisors.
- Value
- ₹42.70 Cr
Euro Pratik Sales Management Change
Euro Pratik Sales Limited appointed Mr. Manish Sacheti as Non-Executive Independent Director and Mr. Manish Baldeva as Secretarial Auditor for a 60-month term.
Euro Pratik Sales Investor Presentation: Key Takeaways
Euro Pratik Sales Limited acquires 56% stake in Fabwood Solutions LLP for ₹42.70 crs, diversifying into architectural wood solutions from decorative surfaces.
Euro Pratik Sales Acquisition Worth ₹42.7 Cr
Euro Pratik Sales board approved a Rs.42.70 Crore acquisition of 56% controlling stake in Fabwood Solutions LLP, which will own Fab Wood's timber and engineered-wood business. The deal is to close by 8 October 2026.
- Value
- ₹42.70 Cr
- Execution
- on or before 8 October 2026
Euro Pratik Sales Annual General Meeting
Euro Pratik Sales Limited conducted its 17th Annual General Meeting on September 22, 2026. Shareholders transacted ordinary and special business items as per the agenda.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.